Cognition & Mood
Nootropic and neuroprotective peptides studied for focus, memory and stress resilience. 15 profiles, 5 sourceable from N1 Aminos.
Semax
Semax is a neuropeptide derived from ACTH with unparalleled ability to simultaneously enhance focus, memory, learning, motivation, and neuroprotection by upregulating BDNF, optimizing dopamine/serotonin balance, improving cerebral blood flow, and suppressing neuroinflammation—essentially optimizing cognitive capacity across all domains simultaneously. Research shows 30-50%+ improvements in attention, memory, motivation, and stress resilience with cognitive enhancement maintained long-term without tolerance development or crash upon discontinuation.
- Route
- Subcutaneous
- Dose
- 300 mcg – 800 mcg
- Cycle
- 12–16 weeks
NAD+
NAD+ (Nicotinamide Adenine Dinucleotide) is your cells’ universal energy and repair currency, essential for ATP production, DNA damage repair, mitochondrial function, epigenetic gene expression, and activation of sirtuins—the “longevity genes” that slow aging at the molecular level. NAD+ levels decline 50% by age 50, explaining why aging tissues struggle with repair, energy production, and disease resistance.
- Route
- Subcutaneous
- Dose
- 50 mg – 100 mg
- Cycle
- 8–16 weeks
Pinealon
Pinealon is a triamino-acid peptide complex (Glu-Asp-Gly) that restores pineal gland function to reestablish youthful circadian rhythms, melatonin production, and neuroprotection against age-related cognitive decline and neurodegeneration. Working at the epigenetic level, it regulates gene expression in brain cells to support cellular metabolism, antioxidant defense, and neuronal plasticity—the foundation of memory, learning, and resilience to stress and aging.
- Route
- Subcutaneous
- Dose
- 200 mcg – 500 mcg
- Cycle
- 8–12 weeks
Selank
Selank is a heptapeptide anxiolytic derived from tuftsin with clinical efficacy equal to benzodiazepine anxiolytics but without sedation, dependence, or cognitive impairment, working through GABAergic enhancement and serotonergic/dopaminergic modulation to create calm without dulling mental clarity. Research shows it reduces generalized anxiety disorder and PTSD symptoms while preserving or enhancing cognitive performance—a combination rarely achieved by conventional psychiatric medications.
- Route
- Subcutaneous
- Dose
- 300 mcg – 500 mcg
- Cycle
- 8–16 weeks
ARA-290
ARA290 · Cibinetide
ARA-290 is a next-generation repair peptide that fixes damaged nerves and calms down overactive inflammation, without the side effects of older anti-inflammatory drugs. It’s engineered from erythropoietin (the hormone that makes red blood cells), but scientists removed the blood-building part and kept only the healing and protective powers—making it unique among peptides.
- Route
- Subcutaneous
- Dose
- 4 mg – 8 mg
- Cycle
- 4–8 weeks
Adamax
Adamax is an enhanced Semax analog featuring N-terminal adamantane acetylation and C-terminal amidation modifications that extend half-life, improve blood-brain barrier penetration, and amplify BDNF expression, neuroplasticity, and cognitive enhancement compared to parent Semax—delivering sustained focus, memory consolidation, and neuroprotection through superior receptor binding affinity and metabolic stability. Structural upgrades enable lower dosing for equivalent or superior effects, targeting ACTH-derived pathways with prolonged receptor occupancy.
- Route
- Subcutaneous
- Dose
- 100 mcg – 300 mcg
- Cycle
- 8–12 weeks
Dihexa
Research Goal: Analyzing the potential for cognitive enhancement and synaptic repair in neurodegenerative models.
- Route
- Topical
- Dose
- 5 mg – 20 mg
- Cycle
- 4–8 weeks
FGL-S
FGL-S is a brain-boosting peptide derived from neural cell adhesion molecules that enhances memory, learning, and neural repair by strengthening connections between brain cells. It mimics natural signals to increase neurotransmitter release, promote new synapse formation, and protect against damage from stress, toxins, or injury.
- Route
- Subcutaneous
- Dose
- 2 mg – 10 mg
- Cycle
- 4–6 weeks
N-Acetyl Semax Amidate
Research Goal: Analyzing the neuroprotective and nootropic properties of the stabilized Semax analog in models of ischemic stroke or ADHD.
- Route
- Subcutaneous
- Dose
- 100 mcg – 500 mcg
- Cycle
- 10–30 days
P21 (P021)
P021
P21 is a tetrapeptide cyclin-dependent kinase (CDK) inhibitor derived from ciliary neurotrophic factor (CNTF) that blocks cell cycle progression by inhibiting CDK-cyclin complexes, triggering apoptosis (programmed cell death) in senescent and cancer cells while allowing healthy cells to continue dividing. It functions as a selective checkpoint regulator, preventing damaged or aged cells from replicating while permitting normal cellular division—essentially quality control for your cellular population.
- Route
- Subcutaneous
- Dose
- 10 mg – 30 mg
- Cycle
- 4–10 weeks
Cortagen
Cortagen is a brain-protecting peptide derived from cortex proteins that repairs neural damage, boosts learning, and shields your nervous system from stress or aging decline. It works by upregulating neurotrophic factors like BDNF (brain-derived neurotrophic factor), which grow and protect neurons while enhancing synaptic plasticity—the brain’s ability to form new connections for memory and skills.
- Route
- Subcutaneous
- Dose
- 1 mg – 2 mg
- Cycle
- 4 weeks
N-Acetyl Selank Amidate
Research Goal: Evaluating the modulation of the serotonin and dopamine systems for the treatment of generalized anxiety and cognitive fatigue.
- Route
- Subcutaneous
- Dose
- 200 mcg – 500 mcg
- Cycle
- 14–30 days
PE-22-28
PE-22-28 is a neuropeptide derived from vasoactive intestinal peptide (VIP) that acts as a rapid-onset antidepressant by blocking TREK-1 potassium channels in mood-regulating brain regions, enhancing neuronal excitability and serotonergic transmission through distinct mechanisms differing from all current antidepressants. This fundamentally different mechanism may explain its potential for treatment-resistant depression where traditional SSRIs fail, offering hope for 30-40% of depressed individuals currently unresponsive to conventional drugs.
- Route
- Subcutaneous
- Dose
- 50 mcg – 200 mcg
- Cycle
- 12–16 weeks
Tesofensine
Tesofensine free base · NS-2330
Research Goal: Analyzing the suppression of appetite and increase in resting energy expenditure through the modulation of neurotransmitter reuptake in the hypothalamus.
- Route
- Oral
- Dose
- 250 mcg – 1 mg
- Cycle
- 12–24 weeks
Humanin
Humanin is a revolutionary mitochondrial-derived peptide that extends lifespan and healthspan by protecting your cells from aging damage, boosting brain health, and optimizing metabolic function at the most fundamental level. It works by activating survival pathways in your mitochondria—your cells’ power plants—protecting them from oxidative stress and dysfunction that accelerates aging and disease.
- Route
- Subcutaneous
- Dose
- 500 mcg – 1 mg
- Cycle
- 20–30 days
Research compounds with a paper trail.
N1 Aminos tests every batch at an independent lab, ships tracked in 3–5 days, and publishes certificates of analysis on request.
Shop N1 Aminos →Code DOSING15 · 15% off first order
Where to trackNever miss a dose or a cycle end.
StackTracker turns any protocol on this site into a daily brief with one-tap logging, half-life graphs and lab-result tracking.
Start a free trial →